image
Healthcare - Biotechnology - NASDAQ - US
$ 1.06
-7.02 %
$ 6.79 M
Market Cap
-0.27
P/E
BALANCE SHEET
4.74 M ASSETS
-17.38%
653 K LIABILITIES
-73.41%
4.08 M EQUITY
24.63%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Adial Pharmaceuticals, Inc.
image
Current Assets 3.2 M
Cash & Short-Term Investments 2.83 M
Receivables 0
Other Current Assets 372 K
Non-Current Assets 1.54 M
Long-Term Investments 1.53 M
PP&E 0
Other Non-Current Assets 3.91 K
Current Liabilities 653 K
Accounts Payable 127 K
Short-Term Debt 0
Other Current Liabilities 526 K
Non-Current Liabilities 437
Long-Term Debt 0
Other Non-Current Liabilities 437

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015
ASSETS
Cash & Cash Equivalents 2.8 4.0 6.1 4.4 6.8 3.9 18.2 K 88 K 0.2
Short Term Investments 0 0 0 0 0 0 0 0 0
Receivables 0 0 0 0 0 0 0 35.1 K 0
Inventory 0 0 0 0 0 0 0 0 0
Other Current Assets 0.4 0.8 0.4 0.7 0.9 0.8 9 K 18.3 K 86.3 K
Total Current Assets 3.2 4.8 6.5 5.1 7.7 4.7 27.2 K 0.1 0.2
PP&E 0 0.2 0.3 0 0 0 0 0 0
Intangible Assets 3.91 K 0.5 0.5 5.61 K 6.17 K 6.74 K 7.3 K 7.86 K 8.43 K
Goodwill 0 0.2 0.2 0 0 0 0 0 0
Long Term Investments 1.5 (0.6) (0.6) 0.3 0 0 0 0 0
Other Long Term Assets 0 0.5 0.5 0 0 0 0 2.25 K 2.25 K
Other Assets 0 0 0 0 0 0 0 0 0
Total Assets 4.7 5.7 7.5 5.5 7.7 4.7 34.5 K 0.2 0.2
LIABILITIES
Accounts Payable 0.1 0.3 0.3 0.6 0.2 99.7 K 0.3 20 K 37.5 K
Short Term Debt 0 0.1 49.6 K 0 0 0 0.7 0.2 0
Other Current Liabilities 0.5 1.4 2.4 0.9 0.3 0.2 752 752 15.6 K
Total Current Liabilities 0.7 1.8 2.7 1.5 0.5 0.3 1.0 0.3 53.1 K
Long Term Debt 0 0.2 0.2 0 0 0 0 0 0
Deferred Tax Income 437 22.9 K 23.4 K 0 0 0 0 0 0
Other Liabilities 437 0.5 1.0 0 0 0 0 0 0
Total Liabilities 0.7 2.5 4.0 1.5 0.5 0.3 1.0 0.3 53.1 K
EQUITY
Common Stock 1.66 K 26.7 K 20.9 K 14.4 K 10.4 K 6.86 K 3.27 K 9.8 9.7
Retained Earnings (68.8) (63.7) (50.9) (31.5) (20.6) (12.0) (0.4) (9.9) (9.5)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 (0.6) 0 0
Total Equity 4.1 3.3 3.5 4.0 7.1 4.4 (1.0) (0.1) 0.2
Total Liabilities and Equity 4.7 5.7 7.5 5.5 7.7 4.7 34.5 K 0.2 0.2
SHARES OUTSTANDING
Common Shares Outstanding 1.4 40.1 K 0.7 0.5 0.4 0.2 0.2 0.2 0.2